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186a Sunday, February 16, 2014shows distinct state 2, 3 and 4 respiration, which can be mimicked in E9.5 WT
hearts by incubation with 200 nM CsA. By E11.5 mitochondrial oxygen con-
sumption in WT hearts is not significantly different when compared to E11.5
CypD KO mice or E13.5 hearts.
In addition, supercomplexes were not detectable in WT hearts of E9.5 and
E11.5 embryos by native electrophoresis or immunocapturing. This may
explain why NADH-cytochrome c reductase activity is not detectable in WT
embryos at E9.5 but in E11.5 or E13.5 WT mice. Furthermore, Cx-1 is in its
de-active form at E9.5 and becomes activated around E11.5.
Our data suggests that at E11.5 the PTP is closed and Cx-1, Cx- 2 and Cx-3 of
the ETC are present, but are not yet arranged in supercomplexes and a coordi-
nated electron transfer is still developing.
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Parkinson’s disease (PD) is one of the most prevalent neurodegenerative disor-
ders, characterized by loss of dopaminergic neuron function; leading to brady-
kinesia andmotor dysfunction. It is observed that various geneswhich have been
implicated in the familial and sporadic forms of the disease are involved in path-
ways which focalize at the mitochondria. This organelle is a central regulator of
cell death, and mitochondrial dysfunction is a common phenomenon associated
with multiple neurodegenerative diseases. Not surprisingly, a clinical screen
identified PD-associated mutations in mitochondrial Hsp70 (mtHsp70), which
is a critical protein involved in mitochondria biogenesis and maintenance of ho-
meostasis. In order to specifically understand the role of the mtHsp70 protein,
we have developed a Saccharomyces cerevisiaemodel for studying the disease
variants in isolation from other players of this multifactorial disease. We gener-
ated the analogousmutants R103W and P486S in yeast mtHsp70 which remark-
ably recapitulated the symptoms of mitochondrial dysfunction in affected
neurons including cell death, increased generation of ROS,mtDNA loss and res-
piratory incompetence. Spectral analysis of a fluorescent carbocyanine dye up-
take in isolated mitochondria indicated compromised membrane potential
gradients as a cause for dysfunction. At the molecular level, circular dichroism
based-thermal melt analyses confirmed the observed in vivo aggregation pro-
pensity of R103W, while P486S exhibited futile enhanced interaction with J-
protein co-chaperone partners thereby resulting in loss of chaperoning activity
by mtHsp70. Remarkably, these altered biochemical properties reflect identical
defects found by us in the human mtHsp70 variants, thereby confirming a direct
involvement of mtHsp70 in PD progression. Thus, by utilizing the significant
structural and functional homology between the yeast and human mtHsp70 pro-
teins, and an integrated in vivo and in vitro approach, we demonstrate the basic
underlying mechanisms of mtHsp70 association with PD.
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The amphipathic tail-anchoring peptide (ATAP) derived from the human anti-
apoptotic protein Bfl-1 is a potent inducer of apoptosis by targeting mitochon-
dria permeability transition. By linking ATAP to an internalizing RGD peptide
(iRGD), selective targeting for ATAP to tumor cells could be achieved. Target-
ing of ATAP-iRGD peptide to tumorigenic cells resulted in mitochondrion-
dependent cell death through release of cytochrome c. Confocal fluorescence
microscopy showed that Dylight488-labeled ATAP-iRGD could effectively
penetrate into cells and distribute along the mitochondria network. Flow cytom-
etry results showed that expression level of integrinaV or integrinaVb3 recep-
tors is higher in ATAP-iRGD sensitive (DU145, KYSE-150 and PC3) cells,
when compared with ATAP-iRGD insensitive (K562 human leukemia cell)
cell line. These results indicate that integrins act as a receptor to mediate uptake
of ATAP-iRGD into the cancer cells. Studies with xenograft model showed that
intravenous injection of ATAP-iRGD could suppress the growth of several hu-
man carcinoma cells implemented into the nude mice. Toxicological studies re-
vealed that repetitive intravenous delivery of ATAP-iRGD did not produce
significant toxicity in different organs of the SV129 mice. Our data suggestthat ATAP-iRGD is a promising agent with high efficacy and limited toxicity
for cancer therapy.
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Myosin II inhibitor Blebbistatin is frequently used for heart immobilization
during imaging experiments involving ischemia/reperfusion (I/R). Here we
investigated the extent to which Blebbistatin modulates critical events during
I/R, such as mitochondrial membrane potential depolarization (DJm), asystole,
and infarction. Langendorff-perfused rabbit hearts were subjected to 60-90 mi-
nutes of ischemia and 180 minutes of reperfusion in the absence (control) or in
the presence of Blebbistatin (5.7 mM). We monitored DJm depolarization
using spectral analysis of confocal images yielded by cationic fluorescent
dye TMRM. We detected the onset of sarcolemmal permeabilization (SP) in
individual myocytes as a massive uptake of anionic dye DiBac4(3) or cell-
impermeable nucleic acid dye YO-PRO1. Control hearts were briefly perfused
with 20 mM potassium at 35 minutes prior to ischemia, and at 30 and 120 mi-
nutes of reperfusion to achieve immobilization necessary for confocal imaging.
In control hearts, cessation of contraction permitted confocal imaging after
10-15 minutes of ischemia. Global and local bipolar electrograms monitored
electrical activity. During ischemia, Blebbistatin significantly (p<0.01) and
proportionally delayed both DJm depolarization (50.5 minutes versus
24.0 minutes in control) and asystole (40.2 minutes versus 22.3 minutes in con-
trol). Upon reperfusion, a heterogeneous DJm recovery was observed in both
groups, but Blebbistatin largely prevented SP events observed on a massive
scale in control hearts. Additionally, Blebbistatin almost completely prevented
infarction in this model (1.953.2% versus 75.057.8% in control by tetrazo-
lium chloride staining). Another electromechanical uncoupler, 2,3-Butane-
dione monoxime (20 mM), did not prevent SP and infarction despite efficient
immobilization. Conclusions: (1) great caution has to be exercised with regard
to interpretation of I/R events observed in the presence of Blebbistatin; (2) the
mechanism(s) of prominent cardioprotection by Blebbistatin may not be fully
explained by immobilization and deserve further study.
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The aim of this work is to study structural and functional organization of energy
metabolism in an ex vivo model of myocardial ischemia-reperfusion, focusing
on the role of mitochondria interactions with cytoskeletal proteins in the regu-
lation of mitochondrial respiration and dynamics. Hearts studied were sub-
jected to perfusion under normoxic, ischemia and ischemia-reperfusion
conditions using Langendorff system.
Hemodynamic measurements showed that reperfusion-dependent left ventricu-
lar diastolic dysfunction is related to increased affinity of respiration for ADP
(low app. Km for ADP). This loss of ADP microcompartmentalization was
associated with decreased functional coupling between oxidative phosphoryla-
tion and mitochondrial creatine kinase. Previous studies have shown that in
healthy adult cardiomyocytes, characterized by high apparent Km for ADP,
cytoskeletal protein b2 tubulin co-localises with mitochondria. Ischemia-
reperfusion injury induces the displacement of b2 tubulin from mitochondrial
position in cardiac muscle fibers with low apparent Km for ADP.
We conclude that ischemia-reperfusion effects on mitochondrial respiration
and dynamics could be related to the disruption of mitochondrial outer mem-
brane porin, VDAC, interaction with cytoskeletal proteins such as b2 tubulin.
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The critical events determining cell death in the aftermath of myocardial
ischemia/reperfusion (I/R) remain poorly understood. Here we investigated
Sunday, February 16, 2014 187athe temporal relationship between the time of apparently complete mitochon-
drial inner membrane potential (DJm) depolarization and the onset of
sarcolemmal permeabilization (SP) during I/R using confocal imaging of the
mitochondrial fluorophore TMRM and the SP indicator YO-PRO1.
Whole rabbit hearts (n=6) were subjected to 60-minutes global ischemia and
180-minutes reperfusion (37oC). In some hearts the electromechanical uncou-
pler 2,3-Butanedione monoxime (20 mM) or temporary perfusion with high
[Kþ] (20 mM) was used to abolish motion during imaging. Two or three
day-old cultured neonatal rat ventricular cardiomyocyte monolayers (NRVCM,
n=3) were subjected to 30-minutes simulated ischemia (including near-anoxia,
pH=6.5, [Kþ]o¼ 8.8 mM and [deoxyglucose]¼ 11 mM, 37oC) and 60-minutes
reperfusion. In hearts and NRVCMs the relatively uniform DJm loss occurred
at 31.255.6 and 18.350.6 minutes of ischemia, respectively, amid absence of
SP events. DJm recovered to a variable degree upon reperfusion in both
models, followed by a secondary and heterogeneous DJm loss in individual
myocytes. Total of 7 myocytes from whole hearts and 6 myocytes from
NRVCMs were tracked throughout the entire period of reperfusion to accu-
rately determine the delay between DJm loss and the earliest detectable SP
(Dt). Dt varied between5.3 and þ14.5 minutes in the heart myocytes and be-
tween 3.0 and þ19.0 minutes in NRVCM myocytes. Excluding outlier cells
with exceedingly large positive Dts, the mean 5 standard deviation of Dt
became 0.854.0 minutes in hearts and 0.253.2 minutes in NRVCMs. Conclu-
sions: (1) criticalDJm loss upon reperfusion typically overlaps in time with the
emergence of sarcolemmal pores of at least 1 nm diameter; (2) 2-3 day-old
NRVCM qualitatively recapitulate the critical I/R events observed in whole
hearts.
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The risk of cardiovascular disease (CVD) and mortality in type-2 diabetic pa-
tients is twice as high as in age-matched healthy subjects. However, the mech-
anisms linking type-2 diabetes with CVD remain poorly understood. We
studied changes in ECC and mitochondrial function in control and diabetic
(db/db) mice. We found no major changes in ECC (Ca transients, cell short-
ening, sarcoplasmic reticulum Ca2þ load) under basal conditions despite
decreased heart-to-body weight. However, under stress conditions (beta-adren-
ergic stimulation) ECC was significantly impaired, and increased ROS gener-
ation and a shift of the redox environment towards oxidation were observed.
Furthermore mitochondrial Ca2þ uptake was increased leading to enhanced
mPTP opening. Mitochondrial respiration monitored using the Seahorse extra-
cellular flux analyzer was decreased in diabetic hearts. We determined that
despite elevated blood glucose levels (395 vs 157 mg/dl in control) and
obesity (BMI was 5.50 vs 3.10 in control), blood levels of beta-
hydroxybutyrate (a ketone body formed in the liver) remained unchanged
(821 vs 784 mM in control). Ketone body oxidation becomes a significant
contributor to overall energy metabolism in extrahepatic tissues under
numerous physiological conditions (neonatal period, starvation, post-
exercise, low carbohydrate diet), when circulating ketone body concentrations
increase from micromolar levels in normal fed state to 7 mM, and can rise to
~20 mM under pathological conditions like diabetic ketoacidosis. We evalu-
ated the effect of elevated beta-hydroxybutyrate levels on ECC and mitochon-
drial function in diabetic hearts. Exposure to 2-10 mM beta-hydroxybutyrate
alone or in the presence of low concentrations of pyruvate (0.1-1 mM)
improved cardiac ECC, preserved the redox environment, decreased ROS gen-
eration and mPTP opening with no effect on mitochondrial Ca2þ uptake.
Therefore, these data suggest that type-2 diabetes patients potentially could
benefit from ketogenic (low carbohydrate) diet which increases beta-
hydroxybutyrate generation.
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MCD inhibition shifts metabolism from fatty acid towards glucose oxidation,
which has therapeutic potential for obesity and myocardial ischemic injury.
However, ~40% of patients with MCD deficiency develop cardiomyopathyduring infancy. The aim of this study was to clarify the early life link between
MCD deficiency, cardiac dysfunction and to identify any underlying systemic
and cardiac metabolic perturbations. MCD knockout mice (-/-) obtained by het-
erozygous breeding exhibited non-Mendelian genotype ratios (31% fewer
MCD-/-) with deaths clustered prior to weaning at 21 days. Further deaths
occurred, such that only n=10 MCD-/- survived >50 days after which no
further increased mortality was observed. Immediately prior to weaning
(18 days) MCD-/- mice had lower body weights (P<0.01), elevated body fat
(P<0.01), hepatic steatosis (P<0.01) and glycogen depletion (P<0.01)
compared to WT littermates. MCD-/- plasma was hyperketonemic, hyperlipi-
demic, had 60% lower lactate levels and elevated markers of cellular damage
(creatine kinase and lactate dehydrogenase P<0.05). MCD-/- hearts exhibited
hypertrophy (heart weight:body weight P<0.001), impaired ejection fraction
(P<0.05) and were energetically compromised (32% lower total adenine nucle-
otide pool P<0.05). However differences between WT and MCD-/- converged
with age, suggesting that, in surviving MCD-/- mice, early cardiac dysfunction
resolves over time. These observations indicate normalisation of the MCD-/-
metabolic phenotype and improved cardiac efficiency when switched from a
high-fat diet (representative of suckling) to a low-fat post-weaning diet, inde-
pendent of any developmental changes. Thus, MCD-/- mice consistently
exhibited cardiac dysfunction and severe metabolic perturbations while on
maternal milk high-fat, low carbohydrate diet and these gradually resolved
post-weaning. This suggests that cardiac insufficiency is a common feature
of MCD deficiency but that severity is dependent on composition of dietary
substrates.
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Deregulation of apoptosis can contribute to diverse pathologic processes. Un-
derstanding its regulatory mechanisms in endothelial cells (ECs) has great
importance for the development of novel therapy strategies for cancer and
cardiovascular pathologies. An oxidative stress with the generation of radical
oxygen species (ROS) is a common mechanism causing ECs’ dysfunction
and apoptosis. The generation of ROS can be triggered by various stimuli
including photodynamic therapy (PDT). The molecular mechanisms underly-
ing PDT, and specifically Hypericin PDT (HypPDT), are not completely un-
derstood, although it has been shown that the sub-cellular Hyp localization
and distribution determine which signaling pathway will lead to cell death.
Cell responses to HypPDT are highly dependent on the Hyp intracellular
localization and accumulation. The mechanisms by which ROS cause or
regulate ECs apoptosis typically include receptor activation, caspase activa-
tion, Bcl-2 family proteins, and mitochondrial dysfunction. We were partic-
ularly interested in Bcl-2 family proteins and investigated their role in
apoptosis of ECs triggered by HypPDT. In the present work, we show that
the presence of Hyp itself has an effect on the distribution of Bcl2 family
members. Presence of Hyp triggers translocation of Bax into mitochondria,
and translocation of Bax and Bcl2 into nuclei in ECs. Further, HypPDT
results in oxidative stress via mitochondrial superoxide production and
primarily in necrotic type of death in HAEC cells. HAEC cell respiratory
control is similar in control cells and in cells after 24 hrs incubation with
Hyp without irradiation, suggesting that even though Hyp presence resulted
in an increased number of apoptotic cells, the mitochondria function
was not affected. However, HypPDT resulted in diminished OCR,
indicating that HypPDT oxidative stress abolished mitochondria function in
intact cells.
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Dynamic protein oscillations spatially regulate the localization of the division
site in the bacterium Escherichia coli. The pole-to-pole oscillations of Min
proteins result on time-average in a nonhomogeneous protein concentration
profile with the highest concentration at the cell poles, where cell division
is inhibited.
Aiming at understanding spatial organization during cell division on the scale
of individual molecules we reconstituted a system of self-organizing Min pro-
teins in artificial micro compartments in a bottom-up approach. Using a devise
